ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

NCT06693830 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Lymphoma, B-Cell
Diffuse Large B Cell Lymphoma
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
High-grade B-cell Lymphoma

Interventions

DEVICE: Phased Variant Enrichment and Detection Sequencing (PhasED-seq)
OTHER: Standard of Care Treatment
OTHER: De-escalated Treatment

Sponsor

Hua-Jay J Cherng, MD

Collaborators

[object Object]
[object Object]
[object Object]